{
    "SPADE_UN_22291": {
        "Sequence Information": {
            "Peptide Name": "IBP",
            "Sequence": "DCAWHLGELVWCT",
            "Sequence Length": 13,
            "Biological Activity": [
                "Antiviral"
            ],
            "Binding Target": "1. Virus entry",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "IgG Fc-binding Motif-Conjugated HIV-1 Fusion Inhibitor Exhibits Improved Potency and in Vivo Half-Life: Potential Application in Combination With Broad Neutralizing Antibodies.",
                    "Pubmed ID": "31805154",
                    "Reference": "PLoS Pathog. 2019;15:e1008082",
                    "Author": "Bi W, Xu W, Cheng L, Xue J, Wang Q, Yu F, Xia S, Li G, Qin C, Lu L, Su L, Jiang S",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/31805154"
                }
            ],
            "Mass": 1532.74,
            "PI": 4.35,
            "Net Charge": -1,
            "Hydrophobicity": 0.42,
            "Frequent Amino Acids": "CLW",
            "Absent Amino Acids": "FIKMNOPQRSUY",
            "Basic Residues": 1,
            "Acidic Residues": 2,
            "Hydrophobic Residues": 6,
            "Polar Residues": 7,
            "Positive Residues": 1,
            "Negative Residues": 2,
            "SPADE ID": "SPADE_UN_22291",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_22289",
                    "Similarity": 1.0,
                    "Sequence": "MTWEEWDKKIEEYTKKIEELIKKSDCAWHLGELVWCT"
                },
                {
                    "SPADE_ID": "SPADE_UN_22290",
                    "Similarity": 1.0,
                    "Sequence": "DCAWHLGELVWCTMTWEEWDKKIEEYTKKIEELIKKS"
                },
                {
                    "SPADE_ID": "SPADE_UN_11716",
                    "Similarity": 0.6666666666666666,
                    "Sequence": "FLGELWNVWKSVF"
                }
            ],
            "Hemolytic Activity": "",
            "Target Organism": "HIV-1 IIIB(IC50 I=>0.5µM),HIV-1 IIIB(IC50 F=>0.5µM),HIV-1 BaL(IC50 I=>0.5µM),HIV-1(IC50 I=>1µM),HIV-1 PsV(IC50 I=>1µM),HIV-1 NL4-3 V38A(IC50 I=>1µM),HIV-1 NL4-3 D36G(IC50 I=>1µM),Human T cell leukemia MT-2(no activity data),Acute myeloid leukemia AML-M7(no activity data)"
        }
    }
}